Rachel B. Kaplan

Holistic Medicine
145 E 15th St Apt 5a
New York, NY 10003

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma.

Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma.

Journal: Journal of experimental therapeutics & oncology
Published: September 06, 2012
Showing 1-1 of 1

Last Updated: 09/26/2026